spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  OFS 

 HSMN NewsFeed - 2 Nov 2023
BD Advances "One-Stick Hospital Stay" Vision with Launch of Next-Generation Needle-Free Blood Draw Technology
Devices FDA Product Launch
 HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Devices Endocrinology Regulatory
 HSMN NewsFeed - 23 Aug 2023
Fresenius Medical Care Announces FDA Clearance of Versi(R)HD with GuideMe Software
Devices FDA
 HSMN NewsFeed - 21 Mar 2022
Dr. Phil Davidson Named Medical Director of Arcuro Medical; Dr. Ken Zaslav Joins Arcuro Scientific Advisory Board
Devices Orthopaedic Personnel
 HSMN NewsFeed - 28 Jul 2021
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
Devices Cardiology FDA
 HSMN NewsFeed - 16 Jun 2021
Pharmaceutical Associates, Inc. appoints Dr. Suketu Sanghvi as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Dec 2020
AIVITA Biomedical Closes $25 Million Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Dec 2020
HiberCell Bolsters Leadership Team with Appointment of Joseph Talamo as Chief Financial Officer and Promotion of Ari Nowacek, M.D., Ph.D., to Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Sep 2020
Israeli Pain Monitoring Startup Medasense Raises $18M in Series C Round
Devices Monitoring Venture Capital
 HSMN NewsFeed - 24 Jun 2020
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn(R) for the Treatment of Alzheimer's Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 15 Jun 2020
Abbott's FreeStyle(R) Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 1 Jun 2020
SwanBio Therapeutics Appoints Steven Zelenkofske, DO, as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 Sep 2019
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Oct 2018
Gauss raises $20 million in Series C from Northwell Health and SoftBank Ventures Korea for AI-Enabled Platform for the Operating Room
Devices Surgery Monitoring Venture Capital
 HSMN NewsFeed - 17 May 2018
ImaginAb Reconstitutes Scientific Advisory Board
Biopharmaceuticals Oncology Radiology Personnel
 HSMN NewsFeed - 14 Aug 2017
Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2017
100,000th Robotic-Arm Assisted Joint Replacement Procedure Performed in the U.S. with Stryker's Mako System
Devices Orthopaedic
 HSMN NewsFeed - 28 Feb 2017
Kevzara(TM) (sarilumab) now available in Canada for the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 16 May 2016
Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 19 Jan 2016
Unique Biomaterial for Hernia Repair Receives FDA 510K Clearance
Devices Surgery FDA
 HSMN NewsFeed - 6 Aug 2015
Virtual Incision Closes $11 Million Equity Financing for First-of-its-Kind Miniaturized Robot for General Surgery
Devices Surgery Venture Capital
 HSMN NewsFeed - 30 Oct 2014
Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing
Devices Orthopaedic Personnel Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2014
MediValve, Ltd. Announces Initiation of post-Market Clinical Evaluations of the acWire(TM) Guidewire at Lenox Hill Hospital (New York)
Devices Interventional
 HSMN NewsFeed - 28 Oct 2013
Lorus Therapeutics Appoints New Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Sep 2013
Cubist Pharmaceuticals Appoints Kenneth Martin to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2013
American Journal of Surgery Publishes Analysis Corroborating Successful Outcomes for novoGI Compression Anastomosis
Devices Surgery
 HSMN NewsFeed - 8 Nov 2012
joimax(R), EndoSphere Spine, LLC and the University of Toledo, Ohio, Have Signed a License Agreement on Endoscopic Cage Technologies
Devices Neurosurgery Orthopaedic Licensing
 HSMN NewsFeed - 16 Apr 2012
QLT Announces the Appointment of Christopher Muller as Chief Commercial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 8 Mar 2012
SensiVida Medical Technologies, Inc. Announces Appointment of Sidney Braginsky as Board Director
Devices Monitoring Personnel
 HSMN NewsFeed - 6 May 2011
Varian Medical Systems Spotlights Advanced Radiosurgery Systems at ISRS Congress in Paris, May 8-12
Devices Oncology
 HSMN NewsFeed - 11 Apr 2011
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
Devices Monitoring Endocrinology
 HSMN NewsFeed - 21 Mar 2011
Bovie Medical Corporation Names J. Robert Saron President; Appoints Two New Members to Its Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 14 Dec 2010
Human Genome Sciences Appoints Colin Goddard, Ph.D., to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2010
QLT Announces Final Results From Its RADICAL Study Evaluating Verteporfin PDT (Visudyne(R)) Combination Therapy in Exudative AMD
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Apr 2010
QLT Names Dipak Panigrahi, M.D., as Chief Medical Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 18 Mar 2010
Dr. Thomas Hofstaetter Named President and CEO of VaxInnate; Dr. Alan Shaw Assumes New Role as Chief Scientific Officer and Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2010
Portola Pharmaceuticals Announces Senior Management and Board Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2010
Linden Acquires Hycor Biomedical Business from Agilent Technologies
Diagnostics Acquisitions
 HSMN NewsFeed - 25 Jan 2010
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Dec 2009
QLT Acquires Early-Stage Ophthalmic Asset for US$7.5 Million
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 9 Dec 2009
Former Wyeth Executive Joins VaxInnate as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2009
6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 25 Nov 2009
QLT announces MGH litigation settlement
Biopharmaceuticals Licensing Litigation Ophthalmology
 HSMN NewsFeed - 23 Oct 2009
Delcath Systems Completes Executive Management Team with Strategic New Hires
Devices Personnel
 HSMN NewsFeed - 19 Oct 2009
QLT restructures Visudyne(R) agreement
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 24 Sep 2009
Portola Pharmaceuticals Announces Promotions of Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2009
QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 May 2009
First-of-its-Kind Study Released at the SGNA 36th Annual Conference Reveals Inconsistency in GI Endoscope Reprocessing
Devices Gastroenterology
 HSMN NewsFeed - 5 May 2009
FDA Grants Accelerated Approval of Avastin for Brain Cancer (Glioblastoma) That Has Progressed Following Prior Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Apr 2009
Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 5 Mar 2009
NeuroMetrix to Reorganize US Sales Operations
Devices Personnel
 HSMN NewsFeed - 29 Jan 2009
DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Jan 2009
Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2008
Q Pharma, Inc. Names Bryan Koslow Vice President of Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2008
Hadasit's Double Lumen PCI Guiding Catheter Prototype Demonstrates to be the First Guiding Catheter to Successfully Enable Administration of Medicine Directly to the Coronary Artery Throughout the Course of a PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Aug 2008
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 23 Jul 2008
AngioDynamics Appoints Vice President of International IRE Sales
Devices Personnel
 HSMN NewsFeed - 9 Jul 2008
FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Jun 2008
Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 May 2008
XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2008
Cyberkinetics Announces Sale of Research Products Business
Devices
 HSMN NewsFeed - 5 May 2008
New Study Finds Bar-Coded Surgical Sponges Improve Patient Safety
Devices Surgery
 HSMN NewsFeed - 17 Mar 2008
QLT announces positive FDA action on Aczone(TM)
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2008
NeuroMetrix and Cyberkinetics Form Joint Venture to Develop Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 19 Feb 2008
Cyberkinetics and Neurometrix Form Joint Venture to Develop Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 18 Jan 2008
QLT reduces workforce as first step in its strategic restructure
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2008
John R. Riesenberger Joins MannKind as Corporate Vice President and Chief Commercialization Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2007
Cyberkinetics Receives FDA Response Letter on Andara(TM) OFS(TM) System for Acute Spinal Cord Injury
Devices Neurology
 HSMN NewsFeed - 3 Dec 2007
Researchers Report Results from Study of Brain Electrical Activity Using Cyberkinetics' NeuroPort(TM) System at the American Epilepsy Society Meeting
Devices Neurology
 HSMN NewsFeed - 26 Nov 2007
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Nov 2007
Cyberkinetics and NeuroMetrix Forge Strategic Alliance and Agree to Pursue Joint Venture Aimed at Developing Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 14 Nov 2007
NeuroMetrix Announces Strategic Alliance with Cyberkinetics
Devices Neurology
 HSMN NewsFeed - 8 Nov 2007
AngioDynamics Highlights Study Showing Significant 5-Year Survival After Ablation of Colorectal Liver Metastases
Devices Oncology
 HSMN NewsFeed - 18 Oct 2007
QLT Completes Acquisition of ForSight Newco II, Inc.
Biopharmaceuticals Ophthalmology Drug Delivery
 HSMN NewsFeed - 9 Oct 2007
QLT acquires leading edge ocular drug delivery system from ForSight Labs
Biopharmaceuticals Ophthalmology Drug Delivery
 HSMN NewsFeed - 31 Aug 2007
Eligard(R) six-month formulation successfully completes European approval procedure
Biopharmaceuticals Drug Delivery Regulatory Oncology
 HSMN NewsFeed - 23 Jul 2007
QLT announces FDA filing and review of Aczone(TM) labeling supplement for removal of blood screening requirement
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 11 Jul 2007
Ortec International: Dr. Costa Papastephanou Appointed CEO
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 29 May 2007
QLT USA, Inc. files Aczone(TM) labeling supplement for removal of blood screening requirement
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 2 May 2007
Dr. John P. Donoghue Presents on Cyberkinetics' BrainGate Neural Interface System in Plenary Session at the AAN Annual Meeting in Boston
Devices Neurology
 HSMN NewsFeed - 1 May 2007
First Extra-Cranial Stereotactic Treatment in Switzerland Takes Place on Lung Cancer Patient Using Varian Equipment
Devices Oncology
 HSMN NewsFeed - 1 May 2007
QLT strengthens its expertise in ocular by adding David A. Saperstein M.D. as interim Chief Medical Officer and Paul L. Kaufman M.D. as Head of the Ocular Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2007
Stratagene Signs Definitive Agreement to Be Acquired by Agilent Technologies
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 20 Feb 2007
Cyberkinetics Files to Market Andara(TM) OFS(TM) Therapy for Acute Spinal Cord Injury under Humanitarian Device Exemption
Devices Neurology Regenerative Medicine FDA
 HSMN NewsFeed - 8 Jan 2007
Access Pharmaceuticals Names Stephen R. Seiler as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2007
Landmark Defibrillator Study Shows Benefits of Dual-Chamber Pacing
Devices Cardiology
 HSMN NewsFeed - 21 Dec 2006
Daxor Announces the Promotions of Stephen Feldschuh to Chief Operating Officer and David Frankel to Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 1 Dec 2006
Eligard(R) six-month formulation approved in Germany
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Nov 2006
Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting
Biopharmaceuticals Neurosurgery Oncology
 HSMN NewsFeed - 20 Nov 2006
New Analyses Demonstrate Positive Effect on Bone With Fosrenol(R) Treatment Compared With Standard Therapy
Biopharmaceuticals
 HSMN NewsFeed - 31 Oct 2006
Boston Scientific Appoints Steven L. Zelenkofske Patient Safety Officer and Vice President, Clinical Sciences for Cardiac Rhythm Management Group
Devices Cardiology Personnel
 HSMN NewsFeed - 17 Oct 2006
Hydromedix Group, Inc. is Pleased to Announce the Appointment of Dr. Jeffery M. Bishop, D.O. as Vice President and Medical Director
Devices Personnel
 HSMN NewsFeed - 15 Oct 2006
Cyberkinetics' BrainGate System Enables Thought-Driven Communication Device and Wheelchair Control for First Stroke Participant in Pilot Clinical Trial
Devices Neurology
 HSMN NewsFeed - 14 Oct 2006
Cyberkinetics' BrainGate System Enables Thought-Driven Computer Control for First ALS Patient in Pilot Clinical Trial
Devices Neurology
 HSMN NewsFeed - 19 Sep 2006
Kurt H. Kruger Joins Cyberkinetics as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 6 Sep 2006
FDA Grants Humanitarian Use Device Designation to Cyberkinetics' Andara(TM) OFS Device for Acute Spinal Cord Injuries
Devices FDA Neurosurgery
 HSMN NewsFeed - 10 Jul 2006
Manhattan Pharmaceuticals Names Michael G. McGuinness as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2006
Cyberkinetics and Minnetronix Finalize Design and Manufacturing Agreement for the Andara(TM) OFS Device to Treat Acute Spinal Cord Injuries
Devices Neurology
 HSMN NewsFeed - 25 May 2006
QLT strengthens corporate development and legal functions with the appointment of Peter J. O'Callaghan as Senior Vice President, Corporate Development and General Counsel
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 46

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 46 additional stories matching:
OFS
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!